Due to published data having attributed increased Treg accumulation to blocking CD4/CD8 T cell, NK cell, and DC-mediated immune response (for review see [33], we believe targeting upstream of Treg recruitment would result in beneficial response to breast cancer progression. The gene discussed is CD8A; the disease is breast carcinoma.